Objectives of the webinar are to:

  • Review heart failure incidence, costs and disease physiology
  • Review CHF medications and their role in symptom management and quality of life
  • Describe the possible drug interactions between CHF and commonly used palliative care medications


  • Dr Kirsten Wentlandt (Head of the Division of Palliative Care at University of Toronto)

    Dr Kirsten Wentlandt

    Head of the Division of Palliative Care at University of Toronto

    More Information

Dr Kirsten Wentlandt is a palliative care physician from Toronto, is the W. Gifford-Jones Professor in Pain Control and Palliative Care, and Head of the Division of Palliative Care at the University of Toronto. Before completing her family medicine and palliative care training, she also completed a PhD, and in her residency did a Masters in Health Sciences (Health Administration). Her clinical work and research are focused on nonmalignant palliative care populations, with ambulatory clinics supporting advanced lung, heart, pulmonary hypertension and transplant populations. She has also been known to sit on various international, national and regional committees that focus on developing strategies to improve access to quality palliative care. 

Sponsors and Partners